Rho-actin signaling to the MRTF coactivators dominates the immediate transcriptional response to serum in fibroblasts

  1. Richard Treisman1,4
  1. 1Transcription Group,
  2. 2Bioinformatics and Biostatistics Group,
  3. 3Advanced Sequencing Facility, Cancer Research UK London Research Institute, London WC2A 3LY, United Kingdom

    Abstract

    The transcription factor SRF (serum response factor) recruits two families of coactivators, the MRTFs (myocardin-related transcription factors) and the TCFs (ternary complex factors), to couple gene transcription to growth factor signaling. Here we investigated the role of the SRF network in the immediate transcriptional response of fibroblasts to serum stimulation. SRF recruited its cofactors in a gene-specific manner, and virtually all MRTF binding was directed by SRF. Much of SRF DNA binding was serum-inducible, reflecting a requirement for MRTF–SRF complex formation in nucleosome displacement. We identified 960 serum-responsive SRF target genes, which were mostly MRTF-controlled, as assessed by MRTF chromatin immunoprecipitation (ChIP) combined with deep sequencing (ChIP-seq) and/or sensitivity to MRTF-linked signals. MRTF activation facilitates RNA polymerase II (Pol II) recruitment or promoter escape according to gene context. MRTF targets encode regulators of the cytoskeleton, transcription, and cell growth, underpinning the role of SRF in cytoskeletal dynamics and mechanosensing. Finally, we show that specific activation of either MRTFs or TCFs can reset the circadian clock.

    Keywords

    Footnotes

    • 4 Corresponding author

      E-mail richard.treisman{at}cancer.org.uk

    • Supplemental material is available for this article.

    • Article published online ahead of print. Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.239327.114.

      Freely available online through the Genes & Development Open Access option.

    • Received February 3, 2014.
    • Accepted March 20, 2014.

    This article, published in Genes & Development, is available under a Creative Commons License (Attribution 4.0 International), as described at http://creativecommons.org/licenses/by/4.0.

    Related Article

    | Table of Contents
    OPEN ACCESS ARTICLE

    Life Science Alliance